Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Dec 15, 2018; 10(12): 496-504
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.496
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.496
Table 3 Time-to-event outcomes
| Group A (n = 54) | Group B (n = 57) | P value | |
| Rate of stent stenosis | < 0.05 | ||
| 6 mo | 18.5 | 43.9 | |
| 12 mo | 55.6 | 82.5 | |
| 24 mo | 83.3 | 96.5 | |
| Survival rate | < 0.05 | ||
| 6 mo | 85.2 | 50.9 | |
| 12 mo | 42.6 | 10.5 | |
| 24 mo | 22.2 | 0 |
- Citation: Wu YF, Wang T, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Liu FQ. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus. World J Gastrointest Oncol 2018; 10(12): 496-504
- URL: https://www.wjgnet.com/1948-5204/full/v10/i12/496.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i12.496